Miller Howard Investments’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $54.8M | Sell |
393,238
-261,540
| -40% | -$36.6M | 1.5% | 26 |
|
|
2025
Q4 | $80.4M | Sell |
654,778
-8,379
| -1% | -$1.02M | 2.43% | 9 |
|
|
2025
Q3 | $73.6M | Sell |
663,157
-540
| -0.1% | -$61.4K | 2.24% | 8 |
|
|
2025
Q2 | $73.6M | Sell |
663,697
-1,160
| -0.2% | -$123K | 2.33% | 9 |
|
|
2025
Q1 | $74.5M | Sell |
664,857
-277,872
| -29% | -$28.7M | 2.37% | 9 |
|
|
2024
Q4 | $87.1M | Sell |
942,729
-115,348
| -11% | -$10.4M | 2.86% | 6 |
|
|
2024
Q3 | $88.7M | Sell |
1,058,077
-10,174
| -1% | -$776K | 2.73% | 4 |
|
|
2024
Q2 | $73.3M | Buy |
1,068,251
+364,204
| +52% | +$24.3M | 2.43% | 6 |
|
|
2024
Q1 | $51.6M | Sell |
704,047
-11,391
| -2% | -$876K | 1.69% | 24 |
|
|
2023
Q4 | $58M | Sell |
715,438
-5,139
| -0.7% | -$400K | 2.02% | 15 |
|
|
2023
Q3 | $54M | Sell |
720,577
-3,440
| -0.5% | -$265K | 1.98% | 18 |
|
|
2023
Q2 | $55.8M | Sell |
724,017
-23,943
| -3% | -$1.91M | 1.99% | 18 |
|
|
2023
Q1 | $62.1M | Buy |
747,960
+8,667
| +1% | +$718K | 2.25% | 13 |
|
|
2022
Q4 | $63.5M | Buy |
739,293
+69,268
| +10% | +$5.49M | 2.3% | 10 |
|
|
2022
Q3 | $41.3M | Sell |
670,025
-149,954
| -18% | -$9.46M | 1.7% | 27 |
|
|
2022
Q2 | $50.7M | Buy |
819,979
+14,933
| +2% | +$925K | 1.96% | 20 |
|
|
2022
Q1 | $47.9M | Sell |
805,046
-54,927
| -6% | -$3.51M | 1.68% | 22 |
|
|
2021
Q4 | $62.4M | Buy |
859,973
+2,715
| +0.3% | +$187K | 2.3% | 11 |
|
|
2021
Q3 | $59.9M | Buy |
857,258
+222,612
| +35% | +$15.6M | 2.47% | 9 |
|
|
2021
Q2 | $43.7M | Buy |
634,646
+1,753
| +0.3% | +$117K | 1.75% | 23 |
|
|
2021
Q1 | $40.9M | Buy |
632,893
+94,592
| +18% | +$6.1M | 1.72% | 25 |
|
|
2020
Q4 | $31.4M | Sell |
538,301
-72,544
| -12% | -$4.38M | 1.48% | 28 |
|
|
2020
Q3 | $38.6M | Sell |
610,845
-43,762
| -7% | -$3.03M | 2.03% | 22 |
|
|
2020
Q2 | $50.4M | Sell |
654,607
-229,546
| -26% | -$17.6M | 2.52% | 11 |
|
|
2020
Q1 | $66.1M | Sell |
884,153
-447,134
| -34% | -$30.9M | 3.38% | 2 |
|
|
2019
Q4 | $86.5M | Buy |
1,331,287
+8,790
| +0.7% | +$572K | 2.72% | 5 |
|
|
2019
Q3 | $83.8M | Sell |
1,322,497
-59,767
| -4% | -$3.91M | 2.61% | 5 |
|
|
2019
Q2 | $93.4M | Buy |
+1,382,264
| New | +$90.9M | 2.74% | 4 |
|
|
2016
Q4 | – | Sell |
-25,619
| Closed | -$2.03M | – | 191 |
|
|
2016
Q3 | $2.03M | Sell |
25,619
-7,710
| -23% | -$626K | 0.04% | 142 |
|
|
2016
Q2 | $2.78M | Sell |
33,329
-282
| -0.8% | -$25K | 0.05% | 133 |
|
|
2016
Q1 | $3.09M | Sell |
33,611
-1,625
| -5% | -$147K | 0.06% | 138 |
|
|
2015
Q4 | $3.57M | Sell |
35,236
-5,167
| -13% | -$538K | 0.06% | 133 |
|
|
2015
Q3 | $3.97M | Buy |
40,403
+2,793
| +7% | +$310K | 0.07% | 124 |
|
|
2015
Q2 | $4.4M | Buy |
+37,610
| New | +$4.11M | 0.06% | 124 |
|
Other funds holding GILD
VCM
VPM
Miller Howard Investments's GILD Position: Q1 2026 in Review
Miller Howard Investments reduced its Gilead Sciences (GILD) stake by 40% in Q1 2026, selling an estimated $36.6M and leaving 393,238 shares worth $54.8M. The position accounts for 1.5% of the portfolio, ranked #26.
Miller Howard Investments first reported a position in GILD in Q2 2015 and has held it in 34 quarters since. The position peaked at $93.4M in Q2 2019. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Miller Howard Investments held 393,238 shares of Gilead Sciences worth $54.8M as of Q1 2026.
- Miller Howard Investments sold 261,540 Gilead Sciences shares in Q1 2026, an estimated $36.6M.
- Gilead Sciences made up 1.5% of Miller Howard Investments's portfolio in Q1 2026, its #26 holding.
- Miller Howard Investments first reported a position in Gilead Sciences in Q2 2015 and has held it in 34 quarters since.
- Miller Howard Investments's Gilead Sciences position peaked at $93.4M in Q2 2019.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Miller Howard Investments's 13F filing for Q1 2026, filed 20 Apr 2026.